Amneal Pharmaceuticals, Inc. Quarterly Operating Lease, Payments in USD from Q1 2019 to Q4 2019

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Amneal Pharmaceuticals, Inc. annual/quarterly Operating Lease, Payments history and growth rate from Q1 2019 to Q4 2019.
  • Amneal Pharmaceuticals, Inc. Operating Lease, Payments for the quarter ending December 31, 2019 was $5.15M.
  • Amneal Pharmaceuticals, Inc. Operating Lease, Payments for the twelve months ending December 31, 2019 was $20.1M.
  • Amneal Pharmaceuticals, Inc. annual Operating Lease, Payments for 2023 was $16M, a 1.12% decline from 2022.
  • Amneal Pharmaceuticals, Inc. annual Operating Lease, Payments for 2022 was $16.2M, a 8.07% increase from 2021.
  • Amneal Pharmaceuticals, Inc. annual Operating Lease, Payments for 2021 was $15M, a 20.1% decline from 2020.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2019 $20.1M $5.15M Oct 1, 2019 Dec 31, 2019 10-K 2021-03-01
Q3 2019 $4.96M Jul 1, 2019 Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $5.11M Apr 1, 2019 Jun 30, 2019 10-Q 2019-08-05
Q1 2019 $4.9M Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.